Variant report
Variant | esv1844724 |
---|---|
Chromosome Location | chr2:212773332-212774751 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539196988 | chr2:212773342-212773343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566565194 | chr2:212773385-212773386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375122099 | chr2:212773442-212773443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114630898 | chr2:212773458-212773459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569347166 | chr2:212773486-212773487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184100061 | chr2:212773520-212773521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73077351 | chr2:212773542-212773543 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs574804490 | chr2:212773601-212773602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533840698 | chr2:212773617-212773618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554074420 | chr2:212773627-212773628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577070237 | chr2:212773629-212773630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs35919515 | chr2:212773671-212773672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545545480 | chr2:212773791-212773792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562361526 | chr2:212773805-212773806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575695447 | chr2:212773829-212773830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541555996 | chr2:212773863-212773864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558273786 | chr2:212773866-212773867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs189431507 | chr2:212773886-212773887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs73077353 | chr2:212773893-212773894 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs540681600 | chr2:212773949-212773950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181034679 | chr2:212773952-212773953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142579849 | chr2:212773958-212773959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538977499 | chr2:212773959-212773960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537032317 | chr2:212774045-212774046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146329007 | chr2:212774051-212774052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186443145 | chr2:212774056-212774057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs79986866 | chr2:212774067-212774068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs76592295 | chr2:212774125-212774126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191293375 | chr2:212774136-212774137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534155798 | chr2:212774145-212774146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs142795248 | chr2:212774174-212774175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181438748 | chr2:212774203-212774204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185908253 | chr2:212774230-212774231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77087484 | chr2:212774237-212774238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375082814 | chr2:212774243-212774244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373682751 | chr2:212774275-212774276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs80182325 | chr2:212774277-212774278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541518701 | chr2:212774285-212774286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555401867 | chr2:212774302-212774303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368459982 | chr2:212774308-212774309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536442366 | chr2:212774309-212774310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554682865 | chr2:212774345-212774346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212772600-212774200 | Weak transcription | Fetal Heart | heart |
2 | chr2:212774200-212774400 | Enhancers | Fetal Heart | heart |